Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Neurofibrosarcoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Gastrointestinal Stromal Tumors 1Fibrosarcoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Doxorubicin 13Gemcitabine 10Ifosfamide 9Trabectedin 7Radiotherapy 7Docetaxel 5Dacarbazine 5pazopanib 3Sunitinib 3Sorafenib 3Nivolumab 3Filgrastim 3pembrolizumab 2pegfilgrastim 2liposomal doxorubicin 2eribulin 2cixutumumab 2belinostat 2Radiotherapy, Conformal 2Imatinib Mesylate 2Chemotherapy, Adjuvant 2Bevacizumab 2tremelimumab 1temsirolimus 1soblidotin 1selinexor 1sargramostim 1saracatinib 1rubitecan 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leiomyosarcoma × brostallicin × Clear all
NCT00041249 2012-07-18

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
64 enrolled
GastrointestinalSarcoma

Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡